Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Sep 3:9:513.
doi: 10.3389/fendo.2018.00513. eCollection 2018.

Developmental Exposure to Endocrine Disrupting Chemicals and Type 1 Diabetes Mellitus

Sarah G Howard  1
Affiliations
Review

Developmental Exposure to Endocrine Disrupting Chemicals and Type 1 Diabetes Mellitus

Sarah G Howard. Front Endocrinol (Lausanne). .

Abstract

Exposure to endocrine disrupting chemicals (EDCs) may have implications for the development of type 1 diabetes mellitus (T1DM), especially if exposure occurs during development. Exposure to EDCs during fetal or early life can disrupt the development of both the immune system and the pancreatic beta cells, potentially increasing susceptibility to T1DM later in life. Developmental exposure to some EDCs can cause immune system dysfunction, increasing the risk of autoimmunity. In addition, developmental exposure to some EDCs can affect beta cell development and function, influencing insulin secretion. These changes may increase stress on the beta cells, and identify them as a target to the immune system. Developmental exposure to EDCs that disrupt metabolism by increasing insulin resistance or obesity may also stress the beta cells. Exposure to these EDCs during development may play a role in the pathogenesis of T1DM, and requires further research.

Keywords: BPA; DOHaD; air pollution; arsenic; endocrine disruptors; persistent organic pollutants; phthalates; type 1 diabetes.

PubMed Disclaimer

References

    1. Gale EA. The rise of childhood type 1 diabetes in the 20th century. Diabetes (2002) 51:3353–61. 10.2337/diabetes.51.12.3353 - DOI - PubMed
    1. Vehik K, Dabelea D. The changing epidemiology of type 1 diabetes: why is it going through the roof? Diabetes Metab Res Rev. (2011) 27:3–13. 10.1002/dmrr.1141 - DOI - PubMed
    1. Knip M, Luopajarvi K, Harkonen T. Early life origin of type 1 diabetes. Semin Immunopathol. (2017) 39:653–67. 10.1007/s00281-017-0665-6 - DOI - PubMed
    1. Thorsen SU, Pipper CB, Eising S, Skogstrand K, Hougaard DM, Svensson J, et al. . Neonatal levels of adiponectin, interleukin-10 and interleukin-12 are associated with the risk of developing type 1 diabetes in childhood and adolescence: a nationwide Danish case-control study. Clin Immunol. (2016) 174:18–23. 10.1016/j.clim.2016.11.007 - DOI - PubMed
    1. Vistnes M, Tapia G, Marild K, Midttun O, Ueland PM, Viken MK, et al. . Plasma immunological markers in pregnancy and cord blood: a possible link between macrophage chemo-attractants and risk of childhood type 1 diabetes. Am J Reprod Immunol. (2018) 79:e12802. 10.1111/aji.12802 - DOI - PubMed

LinkOut - more resources